November 24, 2020

The Niche

Knoepfler lab stem cell blog

Month: May 2020

7 min read

A solid new, blinded placebo-controlled Phase II study from a Duke team clearly shows no benefit of cord blood for autism. Surprisingly, the team has said they are encouraged by the results. As a result, they apparently will continue this kind of work anyway despite their data. In contrast, I see the data as a probable stop sign. Few have been as upbeat over the years as this Duke team about the idea of cord blood for autism spectrum disorder. I have been one …Read More

5 min read

Platelet Rich Plasma (PRP) has been around for a long time, but patients are often confused by it. In part the confusion arises from how it is marketed, which sometimes includes it being described as “stem cells”, which it is not. However, at times it can be as a therapy with stem cells or other biologics, which also adds to the complexity. To help clarify where things stand including on the clinical science, I’m going to do a series of new posts on platelet …Read More

5 min read

The FDA has stem cell clinics squarely on its radar screen now and it’s pulling the trigger with many letters going out to this problematic industry. In the past, sometimes years went by with no letters at all or one letter in total to stem cell clinics so this marks a major shift. Background on lead-up to wave of FDA activity I count 7 letters in a less than two-month span from mid-March to now, which may be the most in history in the …Read More

1 min read

I’m in the process of gathering data on how much people have been paying for their various stem cell and related treatments, but I’d like to hear directly from you as to what was your stem cell treatment cost. Also, how much did you pay for platelet rich plasma, also known as PRP? What about exosome therapy? Yes, not all of these are stem cell treatments, but they are often bundled together under the umbrella term “regenerative therapies.” Sometimes they are used sequentially or …Read More